Craig AG - Search Results

1

Expression, purification, and characterization of a soluble form of the first extracellular domain of the human type 1 corticotropin releasing factor receptor.

Perrin MH, Fischer WH, Kunitake KS, Craig AG, Koerber SC, Cervini LA, Rivier JE, Groppe JC, Greenwald J, Møller Nielsen S, Vale WW. Perrin MH, et al. Among authors: craig ag. J Biol Chem. 2001 Aug 24;276(34):31528-34. doi: 10.1074/jbc.M101838200. Epub 2001 Jun 25. J Biol Chem. 2001. PMID: 11425856 Free article.

2

Alanine series of ovine corticotropin releasing factor (oCRF): a structure-activity relationship study.

Kornreich WD, Galyean R, Hernandez JF, Craig AG, Donaldson CJ, Yamamoto G, Rivier C, Vale W, Rivier J. Kornreich WD, et al. Among authors: craig ag. J Med Chem. 1992 May 15;35(10):1870-6. doi: 10.1021/jm00088a024. J Med Chem. 1992. PMID: 1316969

3

Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor.

Gulyas J, Rivier C, Perrin M, Koerber SC, Sutton S, Corrigan A, Lahrichi SL, Craig AG, Vale W, Rivier J. Gulyas J, et al. Among authors: craig ag. Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10575-9. doi: 10.1073/pnas.92.23.10575. Proc Natl Acad Sci U S A. 1995. PMID: 7479843 Free PMC article.

4

Conformationally restricted competitive antagonists of human/rat corticotropin-releasing factor.

Miranda A, Koerber SC, Gulyas J, Lahrichi SL, Craig AG, Corrigan A, Hagler A, Rivier C, Vale W, Rivier J. Miranda A, et al. Among authors: craig ag. J Med Chem. 1994 May 13;37(10):1450-9. doi: 10.1021/jm00036a010. J Med Chem. 1994. PMID: 8182703

5

Single point D-substituted corticotropin-releasing factor analogues: effects on potency and physicochemical characteristics.

Rivier J, Rivier C, Galyean R, Miranda A, Miller C, Craig AG, Yamamoto G, Brown M, Vale W. Rivier J, et al. Among authors: craig ag. J Med Chem. 1993 Oct 1;36(20):2851-9. doi: 10.1021/jm00072a003. J Med Chem. 1993. PMID: 8411000

6

Constrained corticotropin-releasing factor antagonists with i-(i + 3) Glu-Lys bridges.

Miranda A, Lahrichi SL, Gulyas J, Koerber SC, Craig AG, Corrigan A, Rivier C, Vale W, Rivier J. Miranda A, et al. Among authors: craig ag. J Med Chem. 1997 Oct 24;40(22):3651-8. doi: 10.1021/jm970311t. J Med Chem. 1997. PMID: 9357532

7

Minimal-size, constrained corticotropin-releasing factor agonists with i-(i+3) Glu-Lys and Lys-Glu bridges.

Rivier J, Lahrichi SL, Gulyas J, Erchegyi J, Koerber SC, Craig AG, Corrigan A, Rivier C, Vale W. Rivier J, et al. Among authors: craig ag. J Med Chem. 1998 Jul 2;41(14):2614-20. doi: 10.1021/jm980164e. J Med Chem. 1998. PMID: 9651165

8

Constrained corticotropin-releasing factor (CRF) agonists and antagonists with i-(i+3) Glu-Xaa-DXbb-Lys bridges.

Koerber SC, Gulyas J, Lahrichi SL, Corrigan A, Craig AG, Rivier C, Vale W, Rivier J. Koerber SC, et al. Among authors: craig ag. J Med Chem. 1998 Dec 3;41(25):5002-11. doi: 10.1021/jm980350k. J Med Chem. 1998. PMID: 9836618

9

Astressin analogues (corticotropin-releasing factor antagonists) with extended duration of action in the rat.

Rivier J, Gulyas J, Corrigan A, Martinez V, Craig AG, Taché Y, Vale W, Rivier C. Rivier J, et al. Among authors: craig ag. J Med Chem. 1998 Dec 3;41(25):5012-9. doi: 10.1021/jm980426c. J Med Chem. 1998. PMID: 9836619

10

Corticotropin releasing factor (CRF) agonists with reduced amide bonds and Ser7 substitutions.

Cervini L, Theobald P, Corrigan A, Craig AG, Rivier C, Vale W, Rivier J. Cervini L, et al. Among authors: craig ag. J Med Chem. 1999 Feb 25;42(4):761-8. doi: 10.1021/jm980607e. J Med Chem. 1999. PMID: 10052982

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

171 results

Search Page

Filters